What do we know about the COVID-19 (coronavirus) vaccine?

Unchallenged

Novavax, a Maryland-based company working on an RNA vaccine, has been able to increase antibody response to COVID-19.

The company has reported the results of its Phase 1 trial, which reveal the levels of antibodies generated were about four times higher than those in individuals who are recovering from a COVID-19 infection.

Top Source

Unchallenged

According to the New England Journal of Medicine, 7 known types of COVID-19 vaccines are being tested.

The types of vaccines being tested include inactivated vaccines, subunit vaccines, weakened, live viral vaccines, replicating viral vector vaccines, non-replicating viral vector vaccines, DNA vaccines and mRNA vaccines.

Top Source

Unchallenged

Some COVID-19 vaccines are being developed using cells originally isolated from foetal tissue (often referred to as foetal cells).

The foetal cells being used are derived from two sources (HEK-293 and PER.C6). HEK-293 is a kidney cell line that was isolated from a terminated foetus in 1972. PER.C6 is a retinal cell line that was isolated from a terminated foetus in 1985.

Top Source

The fight against misinformation needs a hero like you.

Add your views to this topic by signing up. You’ll also be able to add or vote on sources, and start new topics. Because if you don’t fight misinformation, who will?

Unchallenged

As of the end of August 2020, scientists were working on over 100 potential vaccines worldwide.

More than 100 vaccine candidates, including one by Moderna, were being developed around the world and about 36 have already entered human clinical trials.

Top Source

Unchallenged
Unchallenged

The fight against misinformation needs a hero like you.

Add your views to this topic by signing up. You’ll also be able to add or vote on sources, and start new topics. Because if you don’t fight misinformation, who will?

Most Validated
Less Validated
Unchallenged
Unchallenged